157 related articles for article (PubMed ID: 24157941)
1. Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer.
Moon HS; Mantzoros CS
Endocr Relat Cancer; 2013 Dec; 20(6):849-59. PubMed ID: 24157941
[TBL] [Abstract][Full Text] [Related]
2. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice.
Moon HS; Liu X; Nagel JM; Chamberland JP; Diakopoulos KN; Brinkoetter MT; Hatziapostolou M; Wu Y; Robson SC; Iliopoulos D; Mantzoros CS
Gut; 2013 Apr; 62(4):561-70. PubMed ID: 22735569
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
4. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
5. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.
Zakikhani M; Dowling RJ; Sonenberg N; Pollak MN
Cancer Prev Res (Phila); 2008 Oct; 1(5):369-75. PubMed ID: 19138981
[TBL] [Abstract][Full Text] [Related]
6. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
8. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.
Yi G; He Z; Zhou X; Xian L; Yuan T; Jia X; Hong J; He L; Liu J
Int J Oncol; 2013 Nov; 43(5):1503-10. PubMed ID: 23982736
[TBL] [Abstract][Full Text] [Related]
9. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
11. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Rattan R; Giri S; Hartmann LC; Shridhar V
J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
13. AMPK/p53 Axis Is Essential for α-Lipoic Acid-Regulated Metastasis in Human and Mouse Colon Cancer Cells.
Park S; Choi SK; Choi Y; Moon HS
J Investig Med; 2015 Oct; 63(7):882-5. PubMed ID: 26312825
[TBL] [Abstract][Full Text] [Related]
14. Combination of metformin and VSL#3 additively suppresses western-style diet induced colon cancer in mice.
Chung EJ; Do EJ; Kim SY; Cho EA; Kim DH; Pak S; Hwang SW; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
Eur J Pharmacol; 2017 Jan; 794():1-7. PubMed ID: 27845068
[TBL] [Abstract][Full Text] [Related]
15. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X; Yan Q; Zhang Z; Du G; Wan X
Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
[TBL] [Abstract][Full Text] [Related]
16. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
17. Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells.
Chae IG; Kim DH; Kundu J; Jeong CH; Kundu JK; Chun KS
Free Radic Res; 2014 Nov; 48(11):1311-21. PubMed ID: 25096910
[TBL] [Abstract][Full Text] [Related]
18. Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs.
Chung MM; Nicol CJ; Cheng YC; Lin KH; Chen YL; Pei D; Lin CH; Shih YN; Yen CH; Chen SJ; Huang RN; Chiang MC
Exp Cell Res; 2017 Mar; 352(1):75-83. PubMed ID: 28159472
[TBL] [Abstract][Full Text] [Related]
19. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.
Kim AY; Lee YS; Kim KH; Lee JH; Lee HK; Jang SH; Kim SE; Lee GY; Lee JW; Jung SA; Chung HY; Jeong S; Kim JB
Mol Endocrinol; 2010 Jul; 24(7):1441-52. PubMed ID: 20444885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
